Published in Clin Cancer Res on May 01, 2008
microRNA Profile in Early-stage Cervical Cancer | NCT04087785
Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol (2009) 5.56
MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest (2010) 2.87
A microRNA expression signature for cervical cancer prognosis. Cancer Res (2010) 2.14
MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One (2011) 2.10
Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls. BMC Biol (2010) 1.80
DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene (2011) 1.76
Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol Cancer (2010) 1.69
MicroRNA profiling and head and neck cancer. Comp Funct Genomics (2009) 1.68
Methylation of an intronic region regulates miR-199a in testicular tumor malignancy. Oncogene (2011) 1.64
Metastamirs: a stepping stone towards improved cancer management. Nat Rev Clin Oncol (2010) 1.58
miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. Am J Pathol (2011) 1.52
Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Mol Cancer (2010) 1.51
MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. PLoS One (2010) 1.50
Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. RNA (2009) 1.48
MicroRNA expression variability in human cervical tissues. PLoS One (2010) 1.47
BANF1 is downregulated by IRF1-regulated microRNA-203 in cervical cancer. PLoS One (2015) 1.44
Non-random integration of the HPV genome in cervical cancer. PLoS One (2012) 1.43
Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta (2011) 1.40
Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future Microbiol (2011) 1.25
Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-β signalling pathway. Nucleic Acids Res (2012) 1.24
Imprinted noncoding RNAs. Mamm Genome (2008) 1.24
Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. Chin J Cancer Res (2013) 1.23
miR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation. PLoS One (2011) 1.21
Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma. Int J Oncol (2013) 1.19
miR-205 expression promotes cell proliferation and migration of human cervical cancer cells. PLoS One (2012) 1.15
Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer. PLoS One (2011) 1.13
A feedback inhibition between miRNA-127 and TGFβ/c-Jun cascade in HCC cell migration via MMP13. PLoS One (2013) 1.10
MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis. BMC Cancer (2010) 1.09
Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix. Clin Epigenetics (2012) 1.06
MetastamiRs: non-coding MicroRNAs driving cancer invasion and metastasis. Int J Mol Sci (2012) 1.04
Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer. Nat Commun (2013) 1.03
Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells. PLoS Pathog (2015) 0.97
miRNAs in the pathogenesis of oncogenic human viruses. Cancer Lett (2010) 0.96
Human papilloma virus, DNA methylation and microRNA expression in cervical cancer (Review). Oncol Rep (2014) 0.96
MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells. Int J Clin Exp Pathol (2014) 0.95
Flexible and versatile as a chameleon-sophisticated functions of microRNA-199a. Int J Mol Sci (2012) 0.93
MicroRNAs and epigenetic regulation in the mammalian inner ear: implications for deafness. Mamm Genome (2009) 0.93
Minireview: The roles of small RNA pathways in reproductive medicine. Mol Endocrinol (2011) 0.92
Overexpressions of microRNA-9 and microRNA-200c in human breast cancers are associated with lymph node metastasis. Cancer Biother Radiopharm (2013) 0.90
MiR-199a regulates cell proliferation and survival by targeting FZD7. PLoS One (2014) 0.89
Next generation sequencing analysis of miRNAs: MiR-127-3p inhibits glioblastoma proliferation and activates TGF-β signaling by targeting SKI. OMICS (2014) 0.89
Regulation of Aerobic Glycolysis by microRNAs in Cancer. Mol Cell Pharmacol (2011) 0.89
Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival. Br J Cancer (2012) 0.88
Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas. Int J Cancer (2014) 0.88
Activation of miR-9 by human papillomavirus in cervical cancer. Oncotarget (2014) 0.87
Heterogeneity of microRNAs expression in cervical cancer cells: over-expression of miR-196a. Int J Clin Exp Pathol (2014) 0.87
A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer. Curr Genomics (2014) 0.86
Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer. Sci Rep (2015) 0.86
Expression profile of circulating microRNAs as a promising fingerprint for cervical cancer diagnosis and monitoring. Mol Clin Oncol (2015) 0.86
Deregulation of the miRNAs expression in cervical cancer: human papillomavirus implications. Biomed Res Int (2013) 0.85
microRNA signature for human pancreatic cancer invasion and metastasis. Exp Ther Med (2012) 0.85
Viral and bacterial aetiologies of epithelial ovarian cancer. Eur J Clin Microbiol Infect Dis (2012) 0.84
microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4. BMC Mol Biol (2015) 0.84
Multistep model of cervical cancer: participation of miRNAs and coding genes. Int J Mol Sci (2014) 0.84
Novel functions and targets of miR-944 in human cervical cancer cells. Int J Cancer (2014) 0.84
Identification and characterization of novel serum microRNA candidates from deep sequencing in cervical cancer patients. Sci Rep (2014) 0.83
Cervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choices. World J Clin Oncol (2015) 0.82
Genome-Wide Expression of MicroRNAs Is Regulated by DNA Methylation in Hepatocarcinogenesis. Gastroenterol Res Pract (2015) 0.82
MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix. World J Surg Oncol (2014) 0.82
Quantifying mRNA and microRNA with qPCR in cervical carcinogenesis: a validation of reference genes to ensure accurate data. PLoS One (2014) 0.82
Up-Regulation of miR-21 Is Associated with Cervicitis and Human Papillomavirus Infection in Cervical Tissues. PLoS One (2015) 0.82
Microrna-199a-5p Functions as a Tumor Suppressor via Suppressing Connective Tissue Growth Factor (CTGF) in Follicular Thyroid Carcinoma. Med Sci Monit (2016) 0.81
The role of miRNAs in cutaneous squamous cell carcinoma. J Cell Mol Med (2015) 0.81
miR-182 induces cervical cancer cell apoptosis through inhibiting the expression of DNMT3a. Int J Clin Exp Pathol (2015) 0.80
A humanized mouse model of HPV-associated pathology driven by E7 expression. PLoS One (2012) 0.80
The mTOR inhibitor AZD8055 inhibits proliferation and glycolysis in cervical cancer cells. Oncol Lett (2012) 0.80
MiR-24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1. Cancer Med (2016) 0.80
HPVbase--a knowledgebase of viral integrations, methylation patterns and microRNAs aberrant expression: As potential biomarkers for Human papillomaviruses mediated carcinomas. Sci Rep (2015) 0.80
Altered miRNA expression in the cervix during pregnancy associated with lead and mercury exposure. Epigenomics (2015) 0.79
Transcription factor KLF4 regulates microRNA-544 that targets YWHAZ in cervical cancer. Am J Cancer Res (2015) 0.79
Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer. Int J Clin Exp Pathol (2015) 0.78
Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer. Am J Physiol Gastrointest Liver Physiol (2016) 0.77
Screening for characteristic microRNAs between pre-invasive and invasive stages of cervical cancer. Mol Med Rep (2015) 0.77
The effect of bortezomib on expression of inflammatory cytokines and survival in a murine sepsis model induced by cecal ligation and puncture. Yonsei Med J (2015) 0.77
MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations. Biomark Insights (2016) 0.77
microRNA-218 expression and its association with the clinicopathological characteristics of patients with cervical cancer. Exp Ther Med (2015) 0.77
MicroRNAs in Gynecological Cancers: Small molecules with big implications. Cancer Lett (2017) 0.76
MicroRNAs in diffuse large B-cell lymphoma. Oncol Lett (2015) 0.76
Therapeutic advances in women's cancers. Front Biosci (Schol Ed) (2011) 0.76
MicroRNA miR-16-1 regulates CCNE1 (cyclin E1) gene expression in human cervical cancer cells. Int J Clin Exp Med (2015) 0.76
HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells. Sci Rep (2015) 0.76
Use of Mature miRNA Strand Selection in miRNAs Families in Cervical Cancer Development. Int J Mol Sci (2017) 0.75
Amplification and up-regulation of MIR30D was associated with disease progression of cervical squamous cell carcinomas. BMC Cancer (2017) 0.75
MicroRNA-148b Acts as a Tumor Suppressor in Cervical Cancer by Inducing G1/S-Phase Cell Cycle Arrest and Apoptosis in a Caspase-3-Dependent Manner. Med Sci Monit (2016) 0.75
Single nucleotide polymorphisms in microRNA genes are associated with cervical cancer susceptibility in a population from Xinjiang Uygur. Oncotarget (2016) 0.75
miR-199a-5p induces cell invasion by suppressing E-cadherin expression in cutaneous squamous cell carcinoma. Oncol Lett (2016) 0.75
MicroRNA-31 functions as an oncogenic microRNA in cutaneous squamous cell carcinoma cells by targeting RhoTBT1. Oncol Lett (2017) 0.75
miRNA Expression Profiles of HPV-Infected Patients with Cervical Cancer in the Uyghur Population in China. PLoS One (2016) 0.75
Genome-Wide Scan for Methylation Profiles in Keloids. Dis Markers (2015) 0.75
MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer. BMC Cancer (2017) 0.75
Bacterial and cytokine mixtures predict the length of gestation and are associated with miRNA expression in the cervix. Epigenomics (2016) 0.75
Cervical and ocular vestibular-evoked myogenic potentials in acute vestibular neuritis. Clin Neurophysiol (2011) 2.24
Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology (2007) 1.68
Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin. Gynecol Oncol (2012) 1.49
Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells. Cancer Res (2009) 1.47
Single-port-access laparoscopic-assisted vaginal hysterectomy versus conventional laparoscopic-assisted vaginal hysterectomy: a comparison of perioperative outcomes. Surg Endosc (2010) 1.46
Clinical characteristics of adnexal masses in Korean children and adolescents: retrospective analysis of 409 cases. J Minim Invasive Gynecol (2010) 1.45
Single port access laparoscopic adnexal surgery. J Minim Invasive Gynecol (2009) 1.40
Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma. Anticancer Res (2012) 1.36
Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer (2007) 1.33
Single-port access laparoscopic-assisted vaginal hysterectomy: a novel method with a wound retractor and a glove. J Minim Invasive Gynecol (2009) 1.32
Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin. Int J Cancer (2009) 1.31
Benign metastasizing leiomyoma with multiple lymph node metastasis: a case report. Cancer Res Treat (2011) 1.29
High expression of microRNA-15b predicts a low risk of tumor recurrence following curative resection of hepatocellular carcinoma. Oncol Rep (2010) 1.28
Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization. Oncogene (2003) 1.27
Adenoid cystic carcinoma of the Bartholin's gland: report of two cases and review of the literature. Gynecol Oncol (2005) 1.25
Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2. Cancer Res (2005) 1.25
Embryonic natural orifice transumbilical endoscopic surgery (E-NOTES) for adnexal tumors. Surg Endosc (2009) 1.22
Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level. Gynecol Oncol (2011) 1.22
The expression of the miRNA-200 family in endometrial endometrioid carcinoma. Gynecol Oncol (2010) 1.20
Single port access laparoscopic adnexal surgery versus conventional laparoscopic adnexal surgery: a comparison of peri-operative outcomes. Eur J Obstet Gynecol Reprod Biol (2010) 1.19
Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer. Cancer Lett (2007) 1.15
Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis. Gynecol Oncol (2011) 1.15
Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study. J Gynecol Oncol (2011) 1.13
Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. Gynecol Oncol (2005) 1.10
Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer. J Mol Cell Biol (2012) 1.10
Activating signal cointegrator 2 required for liver lipid metabolism mediated by liver X receptors in mice. Mol Cell Biol (2003) 1.09
Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion. Mol Cancer (2005) 1.08
AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration. Exp Mol Med (2011) 1.08
Highly sensitive signal detection of duplex dye-labelled DNA oligonucleotides in a PDMS microfluidic chip: confocal surface-enhanced Raman spectroscopic study. Lab Chip (2005) 1.07
Single-port access subtotal hysterectomy with transcervical morcellation: a pilot study. J Minim Invasive Gynecol (2009) 1.07
The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries. Eur J Obstet Gynecol Reprod Biol (2009) 1.06
Homeobox Msx1 interacts with p53 tumor suppressor and inhibits tumor growth by inducing apoptosis. Cancer Res (2005) 1.06
Preoperative serum CA-125 levels and risk of suboptimal cytoreduction in ovarian cancer: a meta-analysis. J Surg Oncol (2010) 1.04
Papillary serous carcinoma in ovaries of normal size: a clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma. Gynecol Oncol (2007) 1.03
The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results. Gynecol Oncol (2009) 1.03
Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition. J Gynecol Oncol (2013) 1.02
Increased toll-like receptor 9 expression in cervical neoplasia. Mol Carcinog (2007) 1.02